Full Citation
Chen Y, Liu Z, Xu H, Liu J, Wang M, Chi Y, et al. Gene regulatory landscape dissected by single-cell four-omics sequencing. Nature. 2026.
Background and Question
Single-cell RNA-seq has transformed disease atlases, but RNA alone cannot fully explain why a cell state exists or whether it is stable, plastic, or targetable. Regulatory interpretation requires epigenomic layers such as chromatin state, nucleosome organization, and genome architecture.
Research question
Can single-cell four-omics sequencing jointly resolve transcriptome and multiple epigenomic regulatory layers to map cellular diversity and gene-control logic more directly?
Methods and Evidence Chain
Developed and applied a single-cell four-omics approach for joint regulatory profiling.
The Nature abstract frames cellular diversity as controlled by transcriptome plus epigenomic regulation, including nucleosome occupancy, chromatin states, and genome architecture.
Used multimodal measurements to dissect gene regulatory landscapes rather than relying on cluster marker genes alone.
Connected cell identity to regulatory state, chromatin context, and gene-expression output.
Technology focus
Developed and applied a single-cell four-omics approach for joint regulatory profiling.
Regulatory layers
The Nature abstract frames cellular diversity as controlled by transcriptome plus epigenomic regulation, including nucleosome occupancy, chromatin states, and genome architecture.
Analysis goal
Used multimodal measurements to dissect gene regulatory landscapes rather than relying on cluster marker genes alone.
Interpretation chain
Connected cell identity to regulatory state, chromatin context, and gene-expression output.
Key Results
The work extends single-cell analysis from expression atlases toward integrated regulatory atlases.
Multiple epigenomic layers provide more direct evidence for regulatory programs controlling cell states.
Four-omics profiling can help distinguish transient expression changes from deeper chromatin-encoded cell-state remodeling.
The framework is immediately relevant to fibrosis, cancer, development, and repair biology where cell states are plastic.
Mechanism Interpretation
The biological logic is layered regulation: genome architecture constrains enhancer-promoter neighborhoods; chromatin state and nucleosome occupancy control accessibility; transcription factors act within that regulatory context; transcript abundance is the downstream observable. Measuring these layers together helps infer which programs maintain a disease cell state.
Mechanism / workflow schematic
Mermaid source is included so the website can render the diagram in supported browsers.
flowchart LR A[Single cell] --> B[Transcriptome] A --> C[Nucleosome occupancy] A --> D[Chromatin state] A --> E[Genome architecture] C --> F[Regulatory context] D --> F E --> F F --> G[Transcription factor programs] G --> B B --> H[Cell state interpretation] F --> I[Testable regulatory targets]
Clinical and Translational Relevance
Clinical relevance
For wound and scar research, four-omics could clarify whether keloid fibroblast activation is a reversible inflammatory state or a chromatin-stabilized fibrotic program. That distinction affects whether treatment should target cytokines, transcription factors, epigenetic regulators, or tissue niches.
Translational value
The paper provides a technology roadmap for future human tissue studies: pair disease biopsies with multimodal regulatory profiling, nominate regulatory drivers, then perturb those drivers in organoids, fibroblast cultures, or spatially mapped tissue models.
Limitations and Critique
Four-omics workflows require demanding sample quality, cost control, and computational expertise.
More modalities per cell can reduce feasible sample size or increase batch risk.
Regulatory correlation still needs perturbation to prove control of phenotype.
Fresh, viable, well-annotated human wound and keloid samples may be harder to obtain than model-system material.
Reviewer-style critique
The paper is important because it raises the standard for single-cell mechanism claims. The caution is that richer modalities do not replace experimental discipline: sample design, matched controls, spatial validation, and perturbation remain decisive.
Practical Next Research Actions
Action 1
Pilot paired scRNA/scATAC/spatial profiling first, then decide whether four-omics depth is worth the added complexity for scar tissue.
Action 2
Use multimodal data to prioritize regulatory nodes that are consistent across expression and chromatin layers.
Action 3
Validate candidate transcription factors or enhancers in primary keloid fibroblasts and skin organoid models.
Action 4
Budget for donor replication and batch controls before increasing modality count.
Evidence-quality judgment
High methodological evidence from a major Nature technology paper; disease-specific conclusions require targeted application.